These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3301153)

  • 1. Efficacy, safety, hemodynamic effects, and pharmacokinetics of high-dose moricizine during short- and long-term therapy.
    Salerno DM; Sharkey PJ; Granrud GA; Asinger RW; Hodges M
    Clin Pharmacol Ther; 1987 Aug; 42(2):201-9. PubMed ID: 3301153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.
    Fitton A; Buckley MT
    Drugs; 1990 Jul; 40(1):138-67. PubMed ID: 2202581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) Investigators
    Am J Cardiol; 1988 Mar; 61(8):501-9. PubMed ID: 2894169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: documentation of efficacy and long-term safety.
    Pratt CM; Yepsen SC; Taylor AA; Mason DT; Miller RR; Quinones MA; Lewis RA
    Am Heart J; 1983 Jul; 106(1 Pt 1):85-91. PubMed ID: 6346845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic drug therapy for suppression of ventricular arrhythmia: experience with 122 patients treated for two years.
    Salerno DM; Fifield J; Hodges M
    J Clin Pharmacol; 1990 Mar; 30(3):226-34. PubMed ID: 2312780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose effect of moricizine on suppression of ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1990 Feb; 65(8):26D-31D; discussion 68D-71D. PubMed ID: 1689534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: results of a prospective, controlled trial.
    Singh SN; DiBianco R; Gottdiener JS; Ginsberg R; Fletcher RD
    Am J Cardiol; 1984 Mar; 53(6):745-50. PubMed ID: 6367416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moricizine: a novel antiarrhythmic agent.
    Carnes CA; Coyle JD
    DICP; 1990; 24(7-8):745-53. PubMed ID: 2197817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indecainide for treatment of ventricular ectopic depolarizations: efficacy, pharmacokinetics, hemodynamic effects and safety.
    Salerno DM; Krejci J; Granrud G; Hodges M
    J Am Coll Cardiol; 1988 Apr; 11(4):843-50. PubMed ID: 3351153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethacizin: a new efficacious Soviet antiarrhythmic drug of the phenothiazine group.
    Rosenshtraukh LV; Shugushev KK; Smetnev AS
    Am Heart J; 1986 Nov; 112(5):932-9. PubMed ID: 3535466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.
    Pratt CM; Podrid PJ; Seals AA; Young JB; Hession M; Lampert S; Quiñones M; Lown B
    Am J Cardiol; 1987 Oct; 60(11):73F-78F. PubMed ID: 3310589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials.
    Morganroth J; Pratt CM; Kennedy HL; Singh SN; Platt ML; Baker BJ; Mason DT
    Am J Cardiol; 1987 Oct; 60(11):48F-51F. PubMed ID: 3310585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of moricizine at rest and during supine bicycle exercise: results in patients with ventricular tachycardia and left ventricular dysfunction.
    Seals AA; English L; Leon CA; Wierman AM; Young JB; Zoghbi W; Quinones MA; Mahler SA; Roberts R; Pratt CM
    Am Heart J; 1986 Jul; 112(1):36-43. PubMed ID: 3524172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic drug therapy for congestive heart failure with focus on moricizine.
    Podrid PJ; Beau SL
    Am J Cardiol; 1990 Feb; 65(8):56D-64D; discussion 68D-71D. PubMed ID: 2407092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethmozine for ventricular premature complexes.
    Gear K; Marcus FI; Huang SK; Fenster PE; Appleton C; Moeller V; Renaud G; Serokman R
    Am J Cardiol; 1986 Apr; 57(11):947-9. PubMed ID: 2421571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum digoxin concentrations during ethmozine antiarrhythmic therapy.
    Kennedy HL; Sprague MK; Redd RM; Wiens RD; Blum RI; Buckingham TA
    Am Heart J; 1986 Apr; 111(4):667-72. PubMed ID: 2420164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.
    Pratt CM; Butman SM; Young JB; Knoll M; English LD
    Am J Cardiol; 1987 Oct; 60(11):52F-58F. PubMed ID: 3310586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a twice-daily dosing regimen for moricizine (ethmozine).
    Morganroth J
    Am Heart J; 1985 Dec; 110(6):1188-92. PubMed ID: 3907314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
    Shugushev KhKh; Rozenshtraukh LV; Smetnev AS; Ponamarenko EL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):16-20. PubMed ID: 2432906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.